ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 140 filers reported holding ANIKA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $469,013 | -54.6% | 15,845 | -65.8% | 0.00% | -50.0% |
| Q2 2022 | $1,034,000 | +154.7% | 46,343 | +386.0% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | -25.6% | 9,536 | -28.7% | 0.00% | -33.3% |
| Q1 2021 | $546,000 | +205.0% | 13,383 | +116.7% | 0.00% | +50.0% |
| Q1 2020 | $179,000 | -79.1% | 6,177 | -70.6% | 0.00% | -71.4% |
| Q2 2019 | $855,000 | -74.8% | 21,040 | -81.2% | 0.01% | -56.2% |
| Q1 2019 | $3,388,000 | -25.0% | 112,020 | -16.6% | 0.02% | -65.2% |
| Q4 2018 | $4,515,000 | +429.3% | 134,333 | +604.0% | 0.05% | +475.0% |
| Q1 2016 | $853,000 | +47.6% | 19,081 | +26.0% | 0.01% | +60.0% |
| Q4 2015 | $578,000 | +85.9% | 15,141 | +60.9% | 0.01% | +25.0% |
| Q2 2015 | $311,000 | -84.2% | 9,413 | -80.5% | 0.00% | -84.6% |
| Q4 2014 | $1,967,000 | -26.6% | 48,281 | -34.0% | 0.03% | -33.3% |
| Q3 2014 | $2,681,000 | – | 73,133 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |